Hemoglobinopathy Clinical Trials
2 recruiting trials for Hemoglobinopathy. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGEarly Phase 1NCT06313398
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Background: Sickle cell disease (SCD) is an inherited disorder of the blood. SCD causes red blood cells (RBCs) to die early. This can lead to a shortage of healthy cells. SCD and...
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 1001 location
RECRUITINGNCT07373639
A Long-term Follow-up Study in Patients Who Received BEAM-101
This is a Long-term Follow-up (LTFU) study in patients who received BEAM-101 in the parent study (Study BTX-AUT-001). Eligible patients who received BEAM-101 will be asked to...
Sponsor: Beam Therapeutics Inc.Enrolling: 5017 locations